michigan semaglutide vomiting law office As obesity rises in New Mexico, advocates push for Medicaid to cover weight loss drugs The Food and Drug Administration

Some brands package a dozen ingredients as a single premium "GLP-1 support" kit

Regrettably, this cannot be said about obesity, for two reasons: 1) We have no similar trials for obesity alone, and 2) the conventional thinking on the cause of obesity

Pancreatitis can cause severe abdominal pain and may lead to hospitalization or long-term health complications

What it does call for is a bit of preparation

Individuals who are overweight or obese (with a BMI of 25 or higher) or have one or more obesity-related conditions may be suitable candidates for GLP-1 therapy

The former is a calculated risk that many researchers accept with the understanding that BUDs include a safety margin